Summary

Persistence Market Research has recently released a comprehensive report on the India Malaria Diagnostics Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• India Malaria Diagnostics Market Size (2025E): US$ 61.6 Mn
• Projected Market Value (2032F): US$ 81.6 Mn
• Market Growth Rate (CAGR 2025 to 2032): 4.1%

India Malaria Diagnostics Market - Report Scope:

The India malaria diagnostics market comprises a broad spectrum of diagnostic technologies aimed at the accurate and early detection of malaria infections caused by Plasmodium species. These technologies include traditional methods such as microscopy, as well as advanced molecular techniques like PCR and rapid diagnostic tests (RDTs). With India being one of the most malaria-endemic countries globally, timely and precise diagnostics play a vital role in national disease control strategies. The rising government initiatives, public health awareness, and technological advancements are transforming the malaria diagnostics landscape in the country.

Market Growth Drivers:

The India malaria diagnostics market is witnessing growth driven by multiple converging factors. Increasing government support for malaria elimination programs under initiatives like the National Framework for Malaria Elimination (NFME) is significantly boosting demand for diagnostic tools. Enhanced public health surveillance, along with the integration of diagnostics into primary healthcare services, is aiding early detection and treatment. Moreover, advancements in diagnostic technologies—such as highly sensitive molecular tests and easy-to-use RDTs—are expanding the reach of testing, especially in remote and rural areas. Growing partnerships between public health agencies and diagnostic manufacturers are also playing a key role in driving market expansion across the country.

Market Restraints:

Despite the upward trend, the India malaria diagnostics market faces certain constraints. The high cost of molecular diagnostic techniques and limited laboratory infrastructure in rural regions pose significant challenges to widespread adoption. Moreover, issues related to the quality and reliability of low-cost rapid diagnostic kits can undermine diagnostic accuracy, affecting treatment outcomes. Inadequate training of healthcare personnel in handling advanced diagnostic tools further hampers their effective utilization. Additionally, the presence of counterfeit or substandard products in the market can reduce trust among end users, posing a barrier to growth.

Market Opportunities:

The India malaria diagnostics market holds promising opportunities for growth and innovation. Continued investment in healthcare infrastructure and the digitalization of diagnostic services are expected to enhance market penetration in underserved areas. The rising burden of drug-resistant malaria strains emphasizes the need for accurate molecular diagnostics, opening avenues for advanced PCR-based platforms. Collaborations with government agencies and NGOs to scale up point-of-care testing in endemic regions provide further growth potential. Moreover, increasing R&D activities to develop low-cost, highly sensitive, and easy-to-deploy diagnostic tools tailored for Indian conditions will allow companies to tap into a large and diverse market base.

Key Questions Answered in the Report:

• What are the primary factors driving the India malaria diagnostics market's growth?
• Which technologies and end-use segments are witnessing the highest adoption in the market?
• How are innovations in diagnostic tools shaping market trends?
• Who are the leading players in the India malaria diagnostics market, and what strategies are they employing to stay competitive?
• What are the emerging opportunities and future projections for the malaria diagnostics market in India?

Competitive Intelligence and Business Strategy:

Leading companies in the India malaria diagnostics market, such as Bio-Rad Laboratories Inc., Access Bio Inc., Abbott India Limited, Hologic, Inc., Roche Diagnostics India Pvt. Ltd., and Sysmex India Private Limited, are leveraging product innovation and expanding their distribution networks to strengthen market presence. These players are focusing on the development of rapid and accurate diagnostic solutions to support public health initiatives. Strategic collaborations with healthcare institutions and government bodies are enabling them to penetrate deeper into regional markets. Additionally, companies like Becton Dickinson India Private Limited, Siemens Healthineers AG, Meridian Bioscience, Inc., Olympus Corporation, Nikon India Pvt Ltd, Beckman Coulter, Inc., and MicroGene Diagnostic Systems (P) Ltd are investing in R&D to improve the cost-effectiveness and sensitivity of diagnostic tools, catering to both public and private sector needs.

Companies Covered in This Report:

• Bio-Rad Laboratories Inc.
• Access Bio Inc.
• Abbott India Limited
• Hologic, Inc.
• Roche Diagnostics India Pvt. Ltd.
• Sysmex India Private Limited
• Becton Dickinson India Private Limited
• Siemens Healthineers AG
• Meridian Bioscience, Inc.
• Olympus Corporation
• Nikon India Pvt Ltd
• Beckman Coulter, Inc.
• MicroGene Diagnostic Systems (P) Ltd

Market Segmentation:

By Technology:

• Microscopy
• Rapid Diagnostic Tests (RDTs)
• Molecular Diagnostic Tests
By End-use:

• Hospitals and Clinics
• Diagnostic Centers
• Academic and Research Institutions

By Region:

• North India
• West India
• South India
• East India

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. India Malaria Diagnostics Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-economic Factors
2.3.1. Public Health Funding and Government Initiatives
2.3.2. International Health Collaborations and FDI in Healthcare
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Value Chain Analysis
3.3. PESTLE Analysis
3.4. Porter’s Five Force Analysis
4. Price Trend Analysis 2019-2032
4.1. Key Highlights
4.2. Key Factors Impacting Technology Costs
4.3. Pricing Analysis by End Use
5. India Malaria Diagnostics Market Outlook
5.1. India Malaria Diagnostics Market Outlook: Technology
5.1.1. Introduction / Key Findings
5.1.2. Historical Market Technology Provider (US$ Mn) and Analysis, By Technology, 2019-2024
5.1.3. Current Market Technology Provider (US$ Mn) and Analysis and Forecast, By Technology, 2025-2032
5.1.3.1. Microscopy
5.1.3.2. Rapid Diagnostic Tests (RDTs)
5.1.3.3. Molecular Diagnostic Tests
5.1.3.3.1. Conventional PCR
5.1.3.3.2. Modernized PCR
5.2. Market Attractiveness Analysis: Technology
5.3. India Malaria Diagnostics Market Outlook: End Use
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Technology Provider (US$ Mn) Analysis, By End Use, 2019-2024
5.3.3. Current Market Technology Provider (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
5.3.3.1. Hospitals and Clinics
5.3.3.2. Diagnostic Centers
5.3.3.3. Academic and Research Institutions
5.4. Market Attractiveness Analysis: End Use
6. India Malaria Diagnostics Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Technology Provider (US$ Mn) Analysis, By Region, 2019-2024
6.3. Current Market Technology Provider (US$ Mn) Analysis and Forecast, By Region, 2025-2032
6.3.1. North India
6.3.2. West India
6.3.3. South India
6.3.4. East India
6.4. Market Attractiveness Analysis: By Region
7. Competition Landscape
7.1. Market Share Analysis, 2025
7.2. Market Structure
7.2.1. Competition Intensity Mapping
7.2.2. Competition Dashboard
7.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
7.3.1. Bio-Rad Laboratories Inc.
7.3.1.1. Overview
7.3.1.2. Solution Portfolio
7.3.1.3. Key Financials
7.3.1.4. Market Developments
7.3.1.5. Market Strategy
7.3.2. Access Bio Inc.
7.3.3. Abbott India Limited
7.3.4. Hologic, Inc.
7.3.5. Roche Diagnostics India Pvt. Ltd.
7.3.6. Sysmex India Private Limited
7.3.7. Becton Dickinson India Private Limited
7.3.8. Siemens Healthineers AG
7.3.9. Meridian Bioscience, Inc.
7.3.10. Olympus Corporation
7.3.11. Nikon India Pvt Ltd
7.3.12. Beckman Coulter, Inc.
7.3.13. MicroGene Diagnostic Systems (P) Ltd
7.3.14. Premier Medical
7.3.15. BIOMÉRIEUX
7.3.16. Others
8. Appendix
8.1. Research Methodology
8.2. Research Assumptions
8.3. Acronyms and Abbreviations